Document Detail


The clinical management of heparin-induced thrombocytopenia.
MedLine Citation:
PMID:  9930559     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Heparin-induced thrombocytopenia (HIT) is an immunologic complication of drug therapy with potentially serious venous and arterial thrombotic sequelae. Recent studies have provided insight into the molecular and cellular basis of HIT underlying the diagnosis and treatment of this syndrome. Because various approaches to HIT treatment have resulted in mixed success, the use of heparin substitutes, other anticoagulant agents, and adjunctive therapy needs to be clarified. For patients with pre-existing conditions such as deep venous thrombosis or pulmonary embolism, new understanding of the clinicopathologic syndrome of HIT offers the promise of improved antithrombotic therapy. The participation of thrombin in HIT suggests that specific (hirudin and argatroban) thrombin inhibitors may be ideal agents for treating acute HIT.
Authors:
J G Kelton
Related Documents :
19008109 - Thromboembolic disease after total knee replacement: experience of 5100 cases.
10639639 - Low-molecular-weight heparin in the initial treatment of proximal deep vein thrombosis.
1252849 - Detection of deep vein thrombosis by doppler angiography.
11338009 - Changes in venous hemodynamics after superficial vein surgery for mixed superficial and...
23266969 - Experimental renal and hepatic artery embolization with a new embolic agent, atelocolla...
23329209 - Exploring the age of intracranial aneurysms using carbon birth dating: preliminary resu...
2932769 - Percutaneous transluminal angioplasty in the region of the aortic bifurcation. the two-...
7877289 - Perceptual rankings of speech quality produced with one-way tracheostomy speaking valves.
9250759 - An anatomical study of a new portal for ankle arthroscopy.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Review    
Journal Detail:
Title:  Seminars in hematology     Volume:  36     ISSN:  0037-1963     ISO Abbreviation:  Semin. Hematol.     Publication Date:  1999 Jan 
Date Detail:
Created Date:  1999-06-14     Completed Date:  1999-06-14     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0404514     Medline TA:  Semin Hematol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  17-21     Citation Subset:  IM    
Affiliation:
McMaster University Medical Center, Ontario, Canada.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Heparin / adverse effects*
Humans
Thrombocytopenia / chemically induced*,  diagnosis,  drug therapy*
Chemical
Reg. No./Substance:
9005-49-6/Heparin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  A mouse model for heparin-induced thrombocytopenia.
Next Document:  Laboratory tests for heparin-induced thrombocytopenia: a multicenter study.